China's Simvastatin Market Report Forecast to 2023

China Simvastatin Market
Market Reports on China Provides the Trending Market Research Report on “Investigation Report on China's Simvastatin Market, 2019-2023” under Drugs Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.

The first widely used statin in China is Simvastatin and the only statin that has been included in China's essential medicine list and needs to complete the consistency evaluation by 2018


Request a free sample copy of Simvastatin Market Report @
http://www.marketreportsonchina.com/marketreports/Sample/Reports/678103

TThe blood lipid levels of Chinese people are rising as China's economy develops and a high-calorie and high-fat diet becomes increasingly prevalent. In 2018, the overall incidence of dyslipidemia in Chinese adults was up to about 40%. As dyslipidemia is a major cause of coronary heart disease, strokes and other atherosclerotic lesions, the treatment of hyperlipidemia can reduce the incidence of these diseases.

Developed by U.S. company MSD, Simvastatin is a semi-synthetic HMG-CoA reductase inhibitor with Lovastatin as the raw material. It was first launched in 1988, and approved by the FDA in Dec. 1991. The trade name of MSD's Simvastatin is Zocor. Simvastatin can prevent the development of atherosclerosis and prevent the relapse of heart diseases, and reduce the risks of nonfatal myocardial infarction and myocardial revascularization.

In 1995, MSD introduced Simvastatin to China. Simvastatin is the first widely used statin in China and the only statin that has been included in China's essential medicine list and needs to complete the consistency evaluation by 2018. And the users of Simvastatin can enjoy some preferential policies. Numerous advertisements and early launch have made Zocor well-known in community-level hospitals. In an agreement with the Chinese government, MSD promised to lower the prices of Simvastatin for a bigger market share.

Our market research shows that the sales value of Simvastatin in sample hospitals in China was about CNY142 million in 2017, and is declining in the competition with other similar drugs. By sales value, China's Simvastatin market is dominated by Hangzhou MSD Pharmaceutical Co., Ltd., MSD, Guangzhou Nanxin Pharmaceutical Co., Ltd., Cinmed Pharmaceuticals, and Yangtze River Pharmaceutical Group Sichuan Hairong Pharmaceutical Co., Ltd. In 2017, the market share by sales value of Hangzhou MSD Pharmaceutical Co., Ltd. was about 63%, which means that branded Simvastatin still has great advantages on the Chinese market.

According to our estimate, Simvastatin will still have certain growth potential in China from 2019 to 2023 as the incidences of cardiovascular diseases keep increasing with the rising urbanization level, aging population and changing lifestyle.

Topics Covered:- Development environment of statins in China
- Supply of and demand for Simvastatin in China
- Major Simvastatin manufacturers in China
- Prices of Simvastatin in China
- Prospect of China's Simvastatin market from 2019 to 2023


About Market Reports on China:
Market Reports on China is thus the one-stop solution for the entire market research requirements with regards to China.
We provide you with insight and analysis on the country’s economic outlook at the national, regional and city level, presenting deep understanding of disparities and evolutionary paths. Get a complete, consistent and concise view of your markets with comprehensive industry reports. Our latest regional databanks, forecasts, and detailed risk ratings will help you to identify risk and opportunities in every industry and develop strategic plans to deal with the competitiveness in the Chinese market.

Contact us:
Market Reports on China
Tel: +91 22 27810772 / 27810773
Email: info@marketreportsonchina.com
Website: http://www.marketreportsonchina.com

Follow us on : Twitter, Facebook, LinkedIn, Google Plus

Comments

Popular posts from this blog

China Plastic Processing Machinery Industry Market Share, Growth & Demand to 2018-2028

China Writing Instruments Market Size, Share, Growth & Forecast 2023

China Beer Market Share, Growth & Demand to 2018-2028